Foreign-Trade Zone 43 Battle Creek, Michigan, Application for Subzone, Pfizer Inc, (Pharmaceutical Products), Kalamazoo, MI, 2018 [E6-237]
Download as PDF
2018
Federal Register / Vol. 71, No. 8 / Thursday, January 12, 2006 / Notices
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
(Docket 1–2006)
erjones on PROD1PC68 with NOTICES
Foreign–Trade Zone 43 Battle Creek,
Michigan, Application for Subzone,
Pfizer Inc, (Pharmaceutical Products),
Kalamazoo, MI
An application has been submitted to
the Foreign–Trade Zones Board (the
Board) by the City of Battle Creek,
grantee of FTZ 43, requesting specialpurpose subzone status for the
manufacturing and warehousing
facilities of Pfizer Inc (Pfizer), located in
Kalamazoo, Michigan. The application
was submitted pursuant to the
provisions of the Foreign–Trade Zones
Act, as amended (19 U.S.C. 81a–81u),
and the regulations of the Board (15 CFR
part 400). It was formally filed on
January 3, 2006.
The Pfizer facilities (3,900 employees)
consist of two sites on 498 acres in
Kalamazoo, Michigan: Site 1 (456 acres)
is located at 7171 Portage Road; and Site
2 (42 acres) is located at 2605 E. Kilgore
Road. The facilities are used for the
manufacturing and warehousing of
pharmaceutical, consumer health care
and animal health care products. Initial
zone savings will come from the
manufacture of Gelfoam, Rogaine,
Zyvox and Revolution (HTS 3006.10,
3305.90, 3004.90, duty–free).
Components and materials sourced from
abroad represent some 6% of all parts
consumed in manufacturing. The
primary inverted tariff savings will
come from the following components:
aromatic butyric/valeric acids,
derivatives of acyclic alcohols,
heterocyclic compounds with oxygen
and lactones (HTS 2905.59, 2915.60,
2932.29 and 2932.99, duty rates range
from duty–free to 6.5%). The company
has also indicated that future plant
manufacturing could involve
pharmaceutical products under the
following HTS numbers: 2309, 2915,
2916, 2917, 2918, 2920, 2921, 2922,
2923, 2924, 2925, 2926, 2928, 2930,
2931, 2932, 2933, 2934, 2935, 2936,
2937, 2938, 2939, 2941, 2942, 3001,
3002, 3003, 3004, 3006, 3305, 3804,
3808, 3822, 3824, 3911, 3913, 3914,
9817. Potential pharmaceutical product
components include the following
categories: 0511, 1108, 1301, 1302,
1504, 1505, 1520, 1521, 1702, 2102,
2106, 2207, 2501, 2519, 2526, 2710,
2811, 2821, 2825, 2827, 2835, 2836,
2840, 2843, 2844, 2845, 2851, 2902,
2903, 2904, 2905, 2906, 2907, 2908,
2909, 2910, 2911, 2912, 2913, 2914,
2915, 2916, 2917, 2918, 2921, 2922,
2923, 2924, 2926, 2930, 2931, 2932,
VerDate Aug<31>2005
15:02 Jan 11, 2006
Jkt 208001
2933, 2934, 2935, 2936, 2937, 2939,
2940, 2941, 2942, 3301, 3306, 3503,
3504, 3505, 3507, 3812, 3815, 3821,
3822, 3824, 3905, 3907, 3910, 3912,
3913, 3914, 3919, 3921, 3923, 4016,
4802, 4804, 4817, 4819, 4821, 4823,
4901, 4908, 4911, 5601, 7010, 7607,
8309, 9018, 9602. In addition, the
application indicates that they may
import products under Chapter 32 or 42
of the HTSUS, but that such products
would be admitted to the subzone in
domestic or privileged–foreign status.
FTZ procedures would exempt Pfizer
from Customs duty payments on the
foreign components used in export
production. Some 35 percent of the
plant’s shipments are exported. On its
domestic sales, Pfizer would be able to
choose the duty rates during Customs
entry procedures that apply to
pharmaceutical products (duty–free) for
the foreign inputs noted above. The
request indicates that the savings from
FTZ procedures would help improve
the plant’s international
competitiveness.
In accordance with the Board’s
regulations, a member of the FTZ staff
has been appointed examiner to
investigate the application and report to
the Board.
Public comment is invited from
interested parties. Submissions (original
and 3 copies) shall be addressed to the
Board’s Executive Secretary at one of
the following addresses:
1. Submissions Via Express/Package
Delivery Services: Foreign-Trade-Zones
Board, U.S. Department of Commerce,
Franklin Court Building—Suite 4100W,
1099 14th St. NW., Washington, DC
20005; or
2. Submissions Via the U.S. Postal
Service: Foreign-Trade-Zones Board,
U.S. Department of Commerce, FCB–
Suite 4100W, 1401 Constitution Ave.
NW., Washington, DC 20230.
The closing period for their receipt is
March 13, 2006. Rebuttal comments in
response to material submitted during
the foregoing period may be submitted
during the subsequent 15-day period (to
March 28, 2006).
A copy of the application and
accompanying exhibits will be available
for public inspection at the Office of the
Foreign–Trade Zones Board’s Executive
Secretary at the first address listed
above, and at the U.S. Department of
Commerce Export Assistance Center,
401 W. Fulton St., Suite 309–C, Grand
Rapids, Michigan 49504.
Dated: January 3, 2006.
Dennis Puccinelli,
Executive Secretary.
[FR Doc. E6–237 Filed 1–11–06; 8:45 am]
BILLING CODE 3510–DS–S
PO 00000
Frm 00006
Fmt 4703
Sfmt 4703
DEPARTMENT OF COMMERCE
International Trade Administration
(A–533–820)
Certain Hot-Rolled Carbon Steel Flat
Products From India: Preliminary
Results of Antidumping Duty
Administrative Review
Import Administration,
International Trade Administration,
Department of Commerce.
SUMMARY: In response to requests by
Essar Steel Ltd. (Essar), a producer/
exporter of the subject merchandise, and
by petitioners,1 the Department of
Commerce (the Department) is
conducting an administrative review of
the antidumping duty order on certain
hot–rolled carbon steel flat products
(HRS) from India. This review covers
one producer/exporter of the subject
merchandise.
The Department has preliminarily
determined that no dumping margin
existed for the manufacturer/exporter
during the POR. If these preliminary
results are adopted in our final results
of administrative review, we will
instruct U.S. Customs and Border
Protection (CBP) to assess antidumping
duties on all appropriate entries.
Interested parties are invited to
comment on these preliminary results of
review. We will issue the final results of
review no later than 120 days from the
date of publication of this notice.
EFFECTIVE DATE: January 12, 2006.
FOR FURTHER INFORMATION CONTACT:
Howard Smith or Jeffrey Pedersen, AD/
CVD Operations, Office 4, Import
Administration, International Trade
Administration, U.S. Department of
Commerce, 14th Street and Constitution
Avenue, NW., Washington, DC 20230,
telephone: (202) 482–5193 or (202) 482–
2769, respectively.
SUPPLEMENTARY INFORMATION:
AGENCY:
Background
On December 3, 2001, the Department
published in the Federal Register the
antidumping duty order on HRS from
India. See Notice of Amended Final
Antidumping Duty Determination of
Sales at Less Than Fair Value and
Antidumping Duty Order: Certain Hot–
Rolled Carbon Steel Flat Products from
India, 66 FR 60194 (December 3, 2001)
(Amended Final Determination). On
December 1, 2004, the Department
published in the Federal Register a
notice of ‘‘Opportunity to Request
Administrative Review’’ of the
1 The petitioners are United States Steel
Corporation (U.S. Steel) and Nucor Corporation
(Nucor).
E:\FR\FM\12JAN1.SGM
12JAN1
Agencies
[Federal Register Volume 71, Number 8 (Thursday, January 12, 2006)]
[Notices]
[Page 2018]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-237]
[[Page 2018]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
(Docket 1-2006)
Foreign-Trade Zone 43 Battle Creek, Michigan, Application for
Subzone, Pfizer Inc, (Pharmaceutical Products), Kalamazoo, MI
An application has been submitted to the Foreign-Trade Zones Board
(the Board) by the City of Battle Creek, grantee of FTZ 43, requesting
special-purpose subzone status for the manufacturing and warehousing
facilities of Pfizer Inc (Pfizer), located in Kalamazoo, Michigan. The
application was submitted pursuant to the provisions of the Foreign-
Trade Zones Act, as amended (19 U.S.C. 81a-81u), and the regulations of
the Board (15 CFR part 400). It was formally filed on January 3, 2006.
The Pfizer facilities (3,900 employees) consist of two sites on 498
acres in Kalamazoo, Michigan: Site 1 (456 acres) is located at 7171
Portage Road; and Site 2 (42 acres) is located at 2605 E. Kilgore Road.
The facilities are used for the manufacturing and warehousing of
pharmaceutical, consumer health care and animal health care products.
Initial zone savings will come from the manufacture of Gelfoam,
Rogaine, Zyvox and Revolution (HTS 3006.10, 3305.90, 3004.90, duty-
free). Components and materials sourced from abroad represent some 6%
of all parts consumed in manufacturing. The primary inverted tariff
savings will come from the following components: aromatic butyric/
valeric acids, derivatives of acyclic alcohols, heterocyclic compounds
with oxygen and lactones (HTS 2905.59, 2915.60, 2932.29 and 2932.99,
duty rates range from duty-free to 6.5%). The company has also
indicated that future plant manufacturing could involve pharmaceutical
products under the following HTS numbers: 2309, 2915, 2916, 2917, 2918,
2920, 2921, 2922, 2923, 2924, 2925, 2926, 2928, 2930, 2931, 2932, 2933,
2934, 2935, 2936, 2937, 2938, 2939, 2941, 2942, 3001, 3002, 3003, 3004,
3006, 3305, 3804, 3808, 3822, 3824, 3911, 3913, 3914, 9817. Potential
pharmaceutical product components include the following categories:
0511, 1108, 1301, 1302, 1504, 1505, 1520, 1521, 1702, 2102, 2106, 2207,
2501, 2519, 2526, 2710, 2811, 2821, 2825, 2827, 2835, 2836, 2840, 2843,
2844, 2845, 2851, 2902, 2903, 2904, 2905, 2906, 2907, 2908, 2909, 2910,
2911, 2912, 2913, 2914, 2915, 2916, 2917, 2918, 2921, 2922, 2923, 2924,
2926, 2930, 2931, 2932, 2933, 2934, 2935, 2936, 2937, 2939, 2940, 2941,
2942, 3301, 3306, 3503, 3504, 3505, 3507, 3812, 3815, 3821, 3822, 3824,
3905, 3907, 3910, 3912, 3913, 3914, 3919, 3921, 3923, 4016, 4802, 4804,
4817, 4819, 4821, 4823, 4901, 4908, 4911, 5601, 7010, 7607, 8309, 9018,
9602. In addition, the application indicates that they may import
products under Chapter 32 or 42 of the HTSUS, but that such products
would be admitted to the subzone in domestic or privileged-foreign
status.
FTZ procedures would exempt Pfizer from Customs duty payments on
the foreign components used in export production. Some 35 percent of
the plant's shipments are exported. On its domestic sales, Pfizer would
be able to choose the duty rates during Customs entry procedures that
apply to pharmaceutical products (duty-free) for the foreign inputs
noted above. The request indicates that the savings from FTZ procedures
would help improve the plant's international competitiveness.
In accordance with the Board's regulations, a member of the FTZ
staff has been appointed examiner to investigate the application and
report to the Board.
Public comment is invited from interested parties. Submissions
(original and 3 copies) shall be addressed to the Board's Executive
Secretary at one of the following addresses:
1. Submissions Via Express/Package Delivery Services: Foreign-
Trade-Zones Board, U.S. Department of Commerce, Franklin Court
Building--Suite 4100W, 1099 14th St. NW., Washington, DC 20005; or
2. Submissions Via the U.S. Postal Service: Foreign-Trade-Zones
Board, U.S. Department of Commerce, FCB-Suite 4100W, 1401 Constitution
Ave. NW., Washington, DC 20230.
The closing period for their receipt is March 13, 2006. Rebuttal
comments in response to material submitted during the foregoing period
may be submitted during the subsequent 15-day period (to March 28,
2006).
A copy of the application and accompanying exhibits will be
available for public inspection at the Office of the Foreign-Trade
Zones Board's Executive Secretary at the first address listed above,
and at the U.S. Department of Commerce Export Assistance Center, 401 W.
Fulton St., Suite 309-C, Grand Rapids, Michigan 49504.
Dated: January 3, 2006.
Dennis Puccinelli,
Executive Secretary.
[FR Doc. E6-237 Filed 1-11-06; 8:45 am]
BILLING CODE 3510-DS-S